Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 266.92%1.88M | -165K | -68.46%405K | 448K | 314.00%1.19M | 71.14%-1.13M | -1.91%1.28M | -88.21%599K | 90.18%-557K | -551.05%-3.9M |
| Net profit before non-cash adjustment | 102.94%1.46M | --2.92M | -129.79%-230K | ---584K | 29.03%-643K | -45.80%-49.66M | 116.87%772K | -865.22%-5.99M | 57.28%-906K | -148.71%-34.06M |
| Total adjustment of non-cash items | -85.55%5.95M | --3.9M | -68.66%560K | --712K | -45.93%777K | 84.41%41.14M | -67.18%1.79M | -16.70%1.36M | -14.31%1.44M | 87.33%22.31M |
| -Depreciation and amortization | -62.28%2.2M | --477K | -57.57%493K | --568K | -48.91%658K | -4.43%5.82M | -30.17%1.16M | -13.62%1.22M | -15.04%1.29M | 5.90%6.09M |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | -79.48%1.88M | ---- | ---- | ---- | 109.93%9.18M |
| -Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | 638.87%33.37M | ---- | ---- | ---- | 195.46%4.52M |
| -Disposal profit | ---- | ---- | ---- | ---- | ---- | -391.16%-1.02M | -318.52%-649K | ---- | ---- | --351.7K |
| -Other non-cash items | 245.02%3.75M | --3.42M | -44.63%67K | --144K | -20.13%119K | -49.86%1.09M | 138.29%121K | -15.29%133K | -7.45%149K | 752.15%2.17M |
| Changes in working capital | -174.71%-5.52M | ---6.98M | 105.88%75K | --320K | 197.24%1.06M | -5.80%7.39M | -389.12%-1.28M | 28.55%5.24M | 79.19%-1.09M | 561.28%7.85M |
| -Change in receivables | 185.97%24.85M | --9.21M | -168.21%-12.86M | --17.75M | 320.40%10.74M | -370.74%-28.9M | 91.43%18.85M | 478.22%6.82M | -445.85%-4.87M | 93.97%10.67M |
| -Change in payables | -124.14%-7.24M | ---12.07M | 145.41%8.53M | ---4.2M | 180.73%511K | 128.87%29.97M | -5,159.66%-18.78M | -9.32%15.15M | 78.65%-633K | 12.55%13.1M |
| -Changes in other current assets | -465.96%-23.13M | ---4.12M | 427.19%4.4M | ---13.23M | -330.72%-10.19M | 139.70%6.32M | 85.12%-1.35M | -54.51%-16.74M | 220.28%4.42M | 0.20%-15.92M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 192.57%217K | 46K | 111.22%74.17K | 78.57%-12K | 227.14%342K | 10.39%-250K | 63.54%-660.9K | |||
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 299.31%2.1M | ---119K | -54.72%576K | --448K | 247.71%1.19M | 76.95%-1.05M | 1.52%1.27M | -80.44%941K | 86.44%-807K | -89.21%-4.56M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -100.93%-21K | --0 | -102.37%-17K | ---1K | 90.63%-3K | 6,965.68%2.27M | 260.80%718K | -101.74%-2K | 59.49%-32K | 110.52%32.09K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---44.14K |
| Net investment product transactions | ---- | ---- | ---- | ---- | ---- | --2M | ---- | ---- | ---- | --0 |
| Interest received (cash flow from investment activities) | ---- | ---- | ---- | ---- | ---- | -88.03%6.23K | --0 | --0 | -97.56%1K | -78.79%52.03K |
| Investing cash flow | -100.49%-21K | --0 | -102.37%-17K | ---1K | 90.32%-3K | 10,591.76%4.28M | 11.32%718K | -101.25%-2K | 18.42%-31K | 167.05%39.99K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 27.57%-125K | ---35K | 43.18%-25K | ---33K | 0.00%-32K | 96.79%-172.59K | 98.18%-44K | 99.48%-21K | -102.78%-32K | -204.74%-5.37M |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | -49.83%2.94M |
| Increase or decrease of lease financing | 74.75%-914K | --190K | 50.36%-342K | ---352K | 52.16%-410K | 14.19%-3.62M | 37.70%-689K | 22.81%-856K | 21.88%-857K | -26.03%-4.22M |
| Interest paid (cash flow from financing activities) | 36.53%-232K | ---50K | 52.05%-35K | ---82K | 15.58%-65K | 15.29%-365.51K | -14.06%-73K | -32.14%-74K | -13.24%-77K | -527.71%-431.47K |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | -100.24%-5.44K | ---- | ---- | ---- | 192.83%2.28M |
| Financing cash flow | 69.47%-1.27M | --105K | 50.12%-402K | ---467K | 47.52%-507K | 13.33%-4.16M | 28.86%-806K | 87.63%-951K | -6,340.00%-966K | -193.83%-4.8M |
| Net cash flow | ||||||||||
| Beginning cash position | -45.98%-2.98M | ---2.17M | 39.84%-2.32M | ---2.3M | -45.99%-2.98M | -128.06%-2.04M | -481.42%-3.86M | -401.10%-3.85M | -128.07%-2.04M | 57.14%7.28M |
| Current changes in cash | 185.62%805K | ---14K | -86.74%157K | ---20K | 137.80%682K | 89.92%-940.24K | 54.77%1.18M | 99.56%-12K | 69.96%-1.8M | -452.20%-9.33M |
| End cash Position | 26.99%-2.18M | ---2.18M | 19.10%-2.17M | ---2.32M | 40.18%-2.3M | -46.00%-2.98M | -250.59%-2.68M | -481.42%-3.86M | -401.10%-3.85M | -128.06%-2.04M |
| Free cash flow | 276.03%2.08M | ---119K | -55.98%559K | --447K | 241.72%1.19M | 76.19%-1.18M | 7.99%1.27M | -80.38%939K | 86.10%-839K | -82.33%-4.95M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.